HOMESeminarExhibitor's Presentation

Site Search:

Tweets

Partner

BioOpto Japan 2014

nanotech 2015

Exhibitor's Presentation

E : English session

S : Simultaneous Interpretation

J : Japanese session

Oct. 15 (Wed.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00        
       
       
       

10:20-10:50

【medU-net】
Tokyo Metropolitan Institute of Medical Science

Innovation of novel drug using pyridoxamine for schizophrenia

10:20-10:50

Nihon University

The novel cerebral infarction improving drug which assumed NMDAR and ASIC a molecular target

10:20-10:35

DiscoveRx

Primary Human Cell Models for Drug Discovery

 
 
 
 

10:35-10:50

RepliCel Life SciencesE

Treating Cellular Deficits with Hair Follicle-Derived Progenitor Stem Cells

10:40-10:55

SCYNEXISS

SCYNEXIS Animal Health

     

10:55-11:25

【medU-net】
St. Marianna University School of Medicine

New anti-inflammatory agent based on a new mechanism

10:55-11:25

Nagoya Institute of Technology

①Visualization of "contractile force" generated by adherent cells
②Specific hydrogen bonding environment in photoactive yellow protein

 

10:55-11:25

Medicon Valley

Innovations in pharma and biotech from the Danish-Swedish life science cluster Medicon Valley, part I

Lundbeck Japan K.K.J

A global pharmaceutical company working with Brain disorders

DanPET ABE

DanPET AB: Alzheimer´s, Orphan Drug Candidate and Biomarker Company

NovozymesE

Novozymes – The World Leader in Bioinnovation

11:00

11:00-11:15

AIMM TherapeuticsE

AIMM Therapeutics, an antibody development company

 
 
       

11:30-12:00

FUKUSHIMA MEDICAL UNIVERSITY

   

11:30-12:00

FUJIFILM Diosynth BiotechnologiesE

From gene to manufacturing: Application of efficient strategies to deliver reliable, high quality biomanufacturing processes

   

11:40-12:10

【medU-net】
University of Toyama

A novel human TCR cloning system confers candidates for cancer gene therapy within 10 days

 
 
 
 
12:00  

12:00-12:15

SCYNEXISS

SCY-078: A novel antifungal for invasive fungal infections

Cancelled

 

12:05-12:35

Chuo University

In silico drug discovery pipeline using FAMS and chooseLD

12:05-12:35

Scottish Development International

Life Science/Chemical Industry in Scotland

English / Japanese

 

12:15-12:45

【medU-net】
SAPPORO MEDICAL UNIVERSITY

The pleiotropic actions of mesenchymal stem cells (MSCs) on intestinal infammation and carcinogenesis

 
 
 
 
     

12:40-13:10

Ehime University(Protein Island Matsuyama)

Cell-free synthesis of membrane protein using wheat cell-free system; introduction of the technology and applications

 

12:40-13:10

Biotechnology & Pharmaceutical Industries Promotion Office (BPIPO), MOEA, TAIWAN

Nang Kuang Pharm

Company Presentation

English / Japanese

Mycenax BiotechE

Total Solution for Protein Drug Development

GlycoNexE

Application of glycan analysis to biomarker discovery and characterization of protein drugs

 

12:45-13:15

Hokkaido University
(JST-ALCA)

Discovery of microorganisms that enhance the grwoth rate of plants by two-folds

12:50-13:20

【medU-net】
Shiga University of Medical Science

13:00
   

13:15-13:45

【medU-net】
Gifu university

Development of 3'-terminus chemical modifications of siRNA/miRNA for suppressing off-target effects

 

13:15-13:45

National Research Program for Biopharmaceuticals, NRPBE

NRPB Instoduction

Development Center for Biotechnology (DCB)

Introduction of Development Center for Biotechnology

EirGenix

Company presentation

 

13:20-14:20

Ministry of Education and Science of the Russian Federation

Federal State Autonomous Educational Institution for Higher Professional Education "North-Caucasus Federal University"S

Vector MSS

New approaches to pain treatment

AELITAS

Spirulina by Ritmico BioTech

Naychnaya IntegraciyE

Wise Soil - organic waste disposal

National Research University of Electronic Technology (MIET)E

First Russian LVAD Sputnik

Perm State UniversityE

Complex ecotechnology for petroleum waste bioconversion and hydrocarboncontaminated site remediation under cold climates

Enterprise Europe Network - St.Petersburg branchE

St.Petersburg Bio Cluster

13:25-13:55

Ibaraki university

iBIX -One of the highest performance pulsed neutron single crystal diffractometer for biological macromolecule in the world

   

13:50-14:20

Graduate School of Bioresources, Mie University

13:50-14:20

Massachusetts Life Sciences CenterE

MASSACHUSETTS: BUILDING THE WORLD'S LEADING LIFE SCIENCES ECOSYSTEM

13:55-14:25

Graduate Scool of Science and Engineering, Ibaraki University, Frontier Research Center for Applied Atomic Sciencse, Ibaraki University

Neutron Crystallographyc Analysis of Ferredoxin-dependent Bilin Reductase PcyA

14:00
     

14:25-14:55

【medU-net】
University of Toyama

Practical application of biopolymer microparticles to strictly control the release of protein drugs

 

14:25-14:55

Nihon University

14:25-14:55

GLOBAL CARE InitiativeE

GLOBAL CARE Initiative, Academia meets Industry

14:30-15:00

【JAPAN BIOLOGICAL INFORMATICS CONSORTIUM】
National Institute of Advanced Industrial Science and Technology (AIST)

     
15:00

15:00-15:30

Ibaraki University

Antimicrobial activity of pantothenol against Staphylococci

 

15:00-16:00

National Institute of Advanced Industrial Science and Technology (AIST)

Computational Biology Research Center

Bioinformatics technology development for genome medicine

Biomedical Research Institute

Drug discovery for the treatment of neglected tropical diseases

Human Technology Research Institute

A primate model of central post stroke pain

15:00-16:00

Belgium-Flanders

Belgium-Flanders a top-level European biopharma clusterE

Flanders Investment & Trade

FlandersBio

VIB

15:05-15:35

Translational Research Initiative, The University of Tokyo

 

15:35-16:05

Kitasato University Kitasato Institute for Life Sciences

 
 

15:45-16:15

Bio-Rad Laboratories

Purification technology for Tag free rProtein by Profinity eXact System

16:00    
     

16:10-16:40

National Center for Global Health and Medicine

 

16:10-16:40

CZECHINVESTE

Life sciences sector and its public support in the Czech Republic

16:10-16:40

BioNet-AsiaE

Current Status of Vaccine Development in Thailand

 

16:20-16:50

French Clusters - UbifranceE

CEA –LETI

Micro and NanoTechnologies for Healthcare and Biology

BCI PHARMA

Design, synthesis and in vitro data of Innovative Kinase Inhibitor library and update on Anti-viral research projects

KEOSYS

Keosys Imaging Services for Clinical trials

     
     
       
       

Oct. 16 (Thu.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00      

10:00-10:40

Embassy of SwedenE

     
     
     

10:20-10:50

【medU-net】
University of Toyama

AScreening method for patiants or pre-patiants with psychiatric diseases by blood exam

10:20-10:50

University of Fukui

 

10:20-10:50

TOKYO UNIVERSITY OF SCIENCE

Nonenzymatic, Enantioconvergent Dynamic Kinetic Resolution (DKR) of Racemic 2-(1H-Pyrrol-1-yl)alkanoic Acids as alpha-Amino Acid Equivalents

10:40-11:10

MEDICON VALLEY ALLIANCEE

Innovations in pharma and biotech from the Danish-Swedish life science cluster Medicon Valley, part II

Leo Pharma

Introducing LEO Pharma

SARomics Biostructures

Accelerating Discovery through Structural Insight

Serendex Pharmaceuticals

Serendex - a Danish pharmaceutical company working within the respiratory field

     

10:55-11:25

【medU-net】
University of Miyazaki

Biomarker candidates of urinary exosomal proteins for renal diseases

10:55-11:25

University of Fukui / Kouchi University of Technology

Label-free detection of influenza virus using optical wave guide device

 
11:00

11:00-11:30

Cyanagen

Reagents for Western blotting and troubleshooting tips

Simultaneous Interpretation

 

11:15-11:45

PolyPeptide GroupE

In Process Controls (IPC's) in Manufacturing of a Peptide Active Pharmaceutical Ingredient (API)

Simultaneous Interpretation

   

11:30-12:00

Japan Science and Technology Agency

・BNA
・SUDx-Biotec

11:30-12:30

National Institute of Advanced Industrial Science and Technology (AIST)

Health Research Institute

Biomedical applications of electroactive polymer actuators

Health Research Institute

Development of camelid derived single-domain VHH antibody

Health Research Institute

Genome editing to generate genetically modified chickens

 

11:35-12:05

TOKYO UNIVERSITY OF SCIENCE

Nanoparticle for highly cell targeting technology

 

11:50-14:20

EU-JAPAN Centre for Industrial Cooperation

  • 3P BiopharmaceuticalsE
    3P Biopharmaceuticals, your partner in protein production
  • ANAXOMICS BIOTECH
    Systems biology solutions for drug discovery, preclinical and clinical development
  • Spanish Association of Biotechnology - ASEBIOE
    Biotech in Spain
  • INSTITUTO BIOMARE
    Biomar an strategic partner in the search and development of new active molecules
  • Bio-XtalJ
    Active antibody discovery and X-ray structure resolution of Ion Channels
  • Coimbra GenomicsE
    Coimbra Genomics - Genetically Informed Medicine
  • CressetE
    Cresset software and services help to design for better compounds
  • DCPrimeE
    Developing the next generation cancer vaccines
  • High Force ResearchE
    High Force Research Ltd - Your Chemical Development Partner for Chemical Synthesis; R&D and more
  • Intelligent PharmaE
    Computational Approaches for Drug Design
  • INVENTIVAE
    INVENTIVA: AN INTEGRATED PLATFORM FOR DRUG DISCOVERY PROGRAMS
  • LipidorE
    AKVANO, a novel sprayable dosage form for topical delivery
  • OcellOE
    OcellO's high content high throughput screening services for compounds and biologics using cultured human tissues
  • OPERONE
    Trends in Sexually Transmitted Diseases (STD) diagnosis:towards an easier way.
  • BSIMsquareE
    Small-molecule therapeutics against transthyretin-related amyloid diseases
  • SanionaE
    Saniona delivering novel transforming ion channel therapeutics
  • SYNthesis med chemE
    SYNthesis med chem .. the "best of both worlds"
  • Berlin Partner for Business and Technology / HealthCapital Berlin-BrandenburgE
    HealthCapital Berlin-Brandenburg: A Leading Hub for Life Sciences in Europe
  • 3B PharmaceuticalsE
    3BP-227, an NTR1-targeted theranostic radiopharmaceutical for the treatment of pancreatic adenocarcinoma
  • TissUseE
    The Multi-Organ-Chip platform: a novel tool for predictive substance testing in vitro
12:00  

12:05-12:35

Tohoku University

Development of Diagnostic Probe for Alzheimer's Disease

 

12:10-12:40

Hiroshima University

 
 

12:35-13:05

Ibaraki University

12:40-13:10

Golden Orchid Brothers

Good News for Managers and Developing Staff Looking for Quick and Profitable Business

 
 
 
 
13:00

13:00-13:10

Okayama University

Overview of Okayama University

 
 

13:10-13:40

Graduate School of Bioresources, Mie University

Challenge to biobutanol production to assume unused agriculture waste raw materials

13:10-13:30

Okayama University

A Project of Cancer Stem Cell Collection Covering All Cancer

13:15-13:45

Chemicals Evaluation and Research Institute, Japan

 

13:30-13:50

Okayama University

Iron controlled cancer therapy

 
 

13:45-14:15

Bio Business Award Japan Executive Committee

TMS

TMS-007, a novel anti-inflammatory thrombolytic that suppresses hemorrhagic transformation, revolutionizes ischemic stroke treatment

13:50-14:20

Nagoya University Academic Research & Industry-Academia-Government Collaboration

13:50-14:10

Okayama University

Activation of anti-tumor immunity by metformin, an anti-type 2 diabetic drug

14:00
 
   
 

14:20-14:50

【medU-net】
Nagasaki Agricultural and Forestry Technical Development Center

Development of the functional foods (mixed fermented teas) using agricultural products in Nagasaki

14:20-14:40

Okayama University

Nano-pathophysiology: Intractability due to structural characteristics in disease foci limiting drug delivery

 
 

14:25-14:55

Holland Bio

14:30-15:00

【JAPAN BIOLOGICAL INFORMATICS CONSORTIUM】
National Institute of Advanced Industrial Science and Technology (AIST)

14:40-15:00

Okayama University

Development of molecular targeted drug for malignant tumor using proteomics

 

14:55-15:25

Kobe Gakuin University

Development of anticancer foods by spinach glycolipids

 
15:00

15:00-16:00

【JAPAN BIOLOGICAL INFORMATICS CONSORTIUM】
FUKUSHIMA MEDICAL UNIVERSITY

15:00-15:20

Okayama University

Practical On-Site Crop Cultivar Determination Method

15:00-16:00

Biotechnology Cluster Bavaria, Germany (BioM Biotech Cluster Development GmbH and Bayern International)E

The Biotechnology Industry in Bavaria (Germany)

15:20-15:40

Okayama University

nstruments at Okayama Medical Innovation Center (OMIC) for Molecular Imaging Researches

 

15:30-16:00

National Cerebral and Cardiovascular Center

 
 
 

15:55-16:25

Hiroshima University

DSE-FRET assay, a novel technology for DNA-protein interactions

16:00    

16:00-16:40

Biology Centre of the Academy of Sciences of the Czech RepublicE

Biology Centre ASCR presents novel research results with biomedical potencial

 

16:05-16:35

French Clusters - UbifranceE

CAPEVAL PHARMA

Global Non-Clinical/Regulatory R&D & Partnership

genOway

Accurate pre-clinical models for Target validation, efficacy, safety and toxicology assessment of NCE, biologics and therapies (nucleic acid, cell therapy, vaccine, etc.) and humanization of target, …

 
 
 
   
     
       
       
       
       
       

Oct. 17 (Fri.)

  Seminar Stage A Seminar Stage B Seminar Stage C Seminar Stage D
10:00        
       
       
       

10:20-10:50

Nihon University

A therapeutic agent to decrease permeability of endothelium

10:20-11:20

Nagoya University Nanotechnology Platform

10:20-10:50

TAMA - TLO

 

 
 
 
 
 
 
     

10:55-11:25

Tottori University

Tumor-specific, replication-competent vaccinia virus foroncolytic virotherapy

10:55-11:25

【medU-net】
Tokyo Medical and Dental University

10:55-11:25

Wallonia Export-Investment AgencyE

①Aseptic Technologies
Closed vial Filling Technology: The future of aseptic filling for ATMP (advanced therapy medicinal products).

②Eurogentec

Specialized biopharmaceutical Contract Manufacturing Services at Eurogentec

11:00
 

11:25-11:55

Tottori University

Development of a serum biomaker and a device for detecting the target specimens in pancreatic cancer

     
 

11:30-12:00

【medU-net】
Hamamatsu University School of Medicine

To provide an anti-tumor therapy using a peptide-targeting novel protein expression in tumors

11:30-12:00

CyanagenE

Reagents for Western blotting and troubleshooting tips

Simultaneous Interpretation

 
 
 
 
   
12:00  

12:00-13:00

SDL Japan

   
 

12:05-12:35

Toyohashi University of Technology

Original RNase-resistant RNA

 
   
   
   
   
   

12:35-13:05

GPC laboratory

   

12:40-13:40

TOYAMA Prefectural University (JST-ERATO Asano Active Enzyme Molecule Project, TOPU BIO RESEARCH)

12:40-13:10

ABA-Invest in AustriaE

Austria: Strong European Platform for Life Sciences

13:00  
 

13:05-13:35

On-Chip Biotechnologies / Mitsui Electronics

13:10-13:40

Japan Agency for Marine-Earth Science and Technology

 

13:15-14:15

Canadian Embassy in JapanE

Kairos Therapeutics

Kairos Therapeutics: Next Generation Antibody-Drug Conjugates

RepliCel Technologies

Developing A Diversified Hair Follicle-Derived Cell Therapy Product Portfolio

Imeka Solutions

State-of-the-art Diffusion MRI in Parkinson’s disease

 
 

13:40-14:10

Osaka Municipal Technical Research Institute

 
 

13:45-14:15

Tokyo Institute of Technology

Development of New Nucleic Acid Drugs

13:50-14:20

【medU-net】
Shiga University of Medical Science

14:00
 

14:15-14:45

【medU-net】
Kawasaki Medical School

Screening Device for asbestos exposure and carcinogenesis using its immunological effects

14:15-14:45

Tokyo Institute of Technology

Metabolome-scale prediction of intermediate compounds in multi-step metabolic pathways with a recursive supervised approach

 
   
 

14:25-14:55

AsterandE

The Ethical Sourcing of Human Biospecimens and their use in Biomarker Identification and Validation

14:30-15:00

【JAPAN BIOLOGICAL INFORMATICS CONSORTIUM】
National Institute of Advanced Industrial Science and Technology (AIST)

Studies on the production of microbial secondary metabolites

 

14:45-15:15

Tokyo Institute of Technology

Future Approach for Synthesis of Bioactive Compounds – Catalytic C–H Bond Activation, Catalytic Asymmetric Synthesis, and Their Fusion –

14:50-15:05

InSpheroE

3D Microtissues: A Versatile Tool for Drug Development and Safety Assessment

 
15:00    

15:05-15:35

Kumamoto University

A new drug for Niemann-Pick disease type C

   
   
 

15:15-15:45

Tokyo Institute of Technology

Metabolic engineering of coryneform bacteria–analysis of glutamate production mechanism and bioproduction

 
   
   
   

15:35-16:05

Kumamoto University

   
   
 

15:45-16:15

Tokyo Institute of Technology

Single cell/surface adhesion material analysis and low temperature sterilization using atmospheric plasma

 
   

15:55-16:25

University of Tsukuba

 
16:00  
   

16:10-16:40

Yokohama City University

 

16:15-16:45

Tokyo Institute of Technology

Bio-based polyester produced from renewable biomass and its material application